Comparison of two pre-exposure treatment regimens in acute organophosphate (paraoxon) poisoning in rats: Tiapride vs. pyridostigmine

详细信息	查看全文 | 推荐本文 |

• 作者：G.A. Petroianu ; M.Y. Hasan ; S.M. Nurulain ; K. Arafat ; R. Sheen ; N. Nagelkerke
• 关键词：Organophosphate ; Paraoxon ; Treatment ; Tiapride ; Pyridostigmine ; Cholinesterase
• 刊名：Toxicology and Applied Pharmacology
• 出版年：2007
• 期刊代码：58_0041008x
• 类别：pha
• 出版时间：March 2007
• 卷：219
• 期：2-3
• 页码：235-240
• 文件大小：179 K

摘要

Recently, the FDA approved the medical use of oral pyridostigmine as prophylactic treatment of possible nerve agent exposure: the concept is to block the cholinesterase transitorily using the carbamate (pyridostigmine) in order to deny access to the active site of the enzyme to the irreversible inhibitor (nerve agent) on subsequent exposure. We have shown previously that tiapride is in vitro a weak inhibitor of acetylcholinesterase and that in rats administration of tiapride before the organophosphate paraoxon significantly decreases mortality.

The purpose of the present study was to compare tiapride- and pyridostigmine-based pretreatment strategies, either alone or in combination with pralidoxime reactivation, by using a prospective, non-blinded study in a rat model of acute high-dose paraoxon exposure.

Groups 1–6 received 1 μMol paraoxon (≈ LD₇₅) groups 2–6 received in addition:

G₂

50 μMol tiapride 30 min before paraoxon

G₃

50 μMol tiapride 30 min before paraoxon and 50 μMol pralidoxime 1 min after paraoxon

G₄

1 μMol pyridostigmine 30 min before paraoxon

G₅

1 μMol pyridostigmine 30 min before paraoxon and 50 μMol pralidoxime 1 min after paraoxon

G₆

50 μMol pralidoxime 1 min after paraoxon

Mortality data were compared using Kaplan–Meier plots and logrank tests. Mortality is statistically significantly influenced by all treatment strategies. Tiapride pretreatment followed by pralidoxime treatment (G₃) is aux par with pyridostigmine pretreatment followed by pralidoxime treatment (G₅). Tiapride pretreatment only (G₂) is inferior to pyridostigmine pretreatment only (G₄). The best results are achieved with pyridostigmine pretreatment only or pralidoxime treatment only (G₄ and G₆).